REFERENCES
Kaminski RM, Gasior M, Carter RB, Witkin JM. Protective efficacy
of neuroactive steroids against cocaine kindled-seizures in mice.
Eur J Pharmacol. 2003;474:217-222.

Koob GF. A role for GABA mechanisms in the motivational effects of alcohol.Biochem Pharmacol. 2004;68:1515-1525.

Leskiewicz M, Budziszewska B, Jaworska-Feil L, Kubera M, Basta-Kaim A, Lason W. Inhibitory effect of some neuroactive steroids on cocaine-induced kindling in mice. Pol J Pharmacol. 2003;55:1131-1136.

Martin-Soelch C, Chevalley AF, Kunig G, et al. Changes in reward-induced brain activation in opiate addicts. Eur J Neurosci. 2001;14:
1360-1368.

McCarthy MM. GABA receptors make teens resistant to input.
Nat Neurosci. 2007;10:397-399.

Mody I. Aspects of the homeostatic plasticity of GABAA receptor-mediated inhibition. J Physiol. 2005;562:37-46.

Morrow AL. Regulation of GABAA receptor function and gene expression in the central nervous system. In: Bradley RJ, and Harris RA, eds. International Review of Neurobiology. Vol. 38. New York: Academic
Press, 1995. pp. 1–41.

N-Wihlback AC, Sundstrom-Poromaa I, Backstrom T. Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders. Psychopharmacology
(Berl). 2006;186:388-401.

NIAAA. Understanding alcohol. 2003. http://science-education.nih.gov/supplements/nih3/alcohol/guide/info-alcohol.htm.

NIAAA. Prescribing medications for alcohol dependence. 2007.
Available at: http://pubs.niaaa.nih.gov/publications/Practitioner/
CliniciansGuide2005/clinicians_guide18.htm.

NIDA. Drugs, brains, and behavior. The science of addiction. 2007.
Available at: http://www.nida.nih.gov/scienceofaddiction/sciofaddiction.pdf.

NIDA. Symptoms of cocaine addiction. 2005. http://www.nida.nih.gov/PDF/DCCA/GDCSession1.pdf

NINDS. Brain basics – know your brain. 2007. Available at: http://www.ninds.nih.gov/disorders/brain_basics/know_your_brain.htm.

Poling J, Kosten TR, Sofuoglu M. Treatment outcome predictors for cocaine
dependence. Am J Drug Alcohol Abuse. 2007;33:191-206.

Reddy DS, Kulkarni SK. Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice. Methods Find Exp Clin Pharmacol. 1997;19:395-405.

Romeo E, Brancati A, De Lorenzo A, et al. Marked decrease of plasma
neuroactive steroids during alcohol withdrawal. Clin Neuropharmacol.
1996;19:366-369.

Steketee JD. Cortical mechanisms of cocaine sensitization. Crit Rev Neurobiol. 2005;17:69-86.

Thompson PM, Hayashi KM, Simon SL, et al. Structural abnormalities in the brains of human subjects who use methamphetamine.
J Neurosci. 2004;24:6028-6036.

Trevisan LA, Boutros N, Petrakis IL, Krystal JH. Complications of alcohol withdrawal: pathophysiological insights. Alcohol Health Res World. 1998;22:61-66.

Tsai GE, Ragan P, Chang R, Chen S, Linnoila VM, Coyle JT. Increased glutamatergic neurotransmission and oxidative stress after alcohol
withdrawal. Am J Psychiatry. 1998;155:726-732.

U.S. Department of Health and Human Services. 1997. Ninth Special Report to the U.S. Congress on Alcohol and Health. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism.

Volkow ND, Wang GJ, Fischman MW, et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature. 1997;386:827-830.

Volkow ND, Fowler JS, Wang GJ. Positron emission tomography and
single-photon emission computed tomography in substance abuse research. Semin Nucl Med. 2003;33:114-128.

Weiss F, Ciccocioppo R, Parsons LH, et al. Compulsive drug-seeking
behavior and relapse. Neuroadaptation, stress, and conditioning factors.
Ann N Y Acad Sci. 2001;937:1-26.

Wilcox C, Brizendine L. For women only: hormones may prevent addiction
relapse. J Fam Practice. 2006;5:1. Available at: http://www.jfponline.com/Pages.asp?AID=4311

Wong CG, Gibson KM, Snead OC 3rd. From the street to the brain:
neurobiology of the recreational drug gamma-hydroxybutyric acid.
Trends Pharmacol Sci. 2004;25:29-34.